Physician

Priya Chokshi, MD

According to 2025 Medicare claims, Priya Chokshi, MD (NPI: 1245676303) practices rheumatology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is TRABECULAR MEDICAL GROUP, LLC (NPI: 1427622661; TIN: 851604336) and primary practice location at 08724-3016.

Chokshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 498 traditional Medicare patients, billed 156,076 HCPCS/CPT codes, and received $2,785,236 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,207 prescription claims across 263 beneficiaries totaling $3,049,784 in drug costs, led by Strensiq (Asfotase Alfa). Open Payments data shows 16 records totaling $595. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $21,438 to $2,785,236. Similarly, Part D prescription costs have risen steadily, from $594 to $3,049,784. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2019 Medicare payment: $21,438 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $29,269 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $26,952 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $58,725 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $829,202 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,785,236 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201997226$21,438
2020135323$29,269
2021115319$26,952
20221232,163$58,725
202328144,672$829,202
2024498156,076$2,785,236

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $594 (USD; Tot_Drug_Cst)2016 Drug cost: $18,770 (USD; Tot_Drug_Cst)2017 Drug cost: $83,388 (USD; Tot_Drug_Cst)2018 Drug cost: $163,616 (USD; Tot_Drug_Cst)2019 Drug cost: $133,281 (USD; Tot_Drug_Cst)2020 Drug cost: $340,777 (USD; Tot_Drug_Cst)2021 Drug cost: $454,018 (USD; Tot_Drug_Cst)2022 Drug cost: $480,744 (USD; Tot_Drug_Cst)2023 Drug cost: $1,193,487 (USD; Tot_Drug_Cst)2024 Drug cost: $3,049,784 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R20$594
20161558$18,770
201726132$83,388
201840170$163,616
201982364$133,281
2020130835$340,777
2021144947$454,018
2022132647$480,744
2023156509$1,193,487
20242631,207$3,049,784

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more85137$137
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more231510$98
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle86240$60
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's233495$13
96372Injection of drug or substance under skin or into muscle114195$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
StrensiqAsfotase Alfa22542$2,170,390
Humira(Cf) PenAdalimumab441,288$318,749
Enbrel SureclickEtanercept331,120$288,441
Orencia ClickjectAbatacept14392$75,633
TeriparatideTeriparatide13364$43,807

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$595ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Priya Chokshi, MD?

Tedicare shows public-source Medicare data for Priya Chokshi, MD (NPI 1245676303), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priya Chokshi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Priya Chokshi, MD?

Priya Chokshi, MD is linked to TRABECULAR MEDICAL GROUP, LLC (billing NPI 1427622661) in the available physician profile data.

Does Priya Chokshi, MD have Open Payments data?

Priya Chokshi, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.